Chronic pain (neuropathic pain, inflammatory pain, cancer pain) is a major health problem. Opiate-based drugs, such as morphine and morphine derivatives, are the primary standard of care for the treatment of chronic pain.  Unfortunately, patients develop tolerance to opiates due to desensitization of the opiate receptor.  Thus, alternative anti-nociceptive ("pain killing") pathways need to be explored for treatment of chronic pain. The N-type voltage-gated Ca2+ channels (CaV2.2s) in dorsal root ganglia neurons is a well validated target for chronic pain (1, 2). We previously demonstrated the interaction between CaV2.2 and the first PDZ domain of molecular adaptor protein Mint1 (3). In additional experiments we demonstrated that carboxyl-terminal association of CaV2.2 protein with the Mint1-PDZ domain plays an important role in synaptic targeting and function of N-type Ca2+ channels (4). The following describes a homogeneous terbium time-resolved fluorescence resonance energy transfer (HTRF) HTS assay to identify small molecule inhibitors of association between Mint1-PDZ domains and carboxyl-terminal peptide present in the long C-terminal splice variant of CaV2.2 pore-forming subunit of N-type calcium channels (NC peptide).  Compounds that disrupt the interaction would result in decrease of TR-FRET ratio and are detected in the assay. The C-terminal sequence in rat and human CaV2.2 sequences are highly conserved.  Small molecules identified in the screening would serve as useful probes for studies of synaptic function of N-type Ca2+ channels, its validation as a therapeutic target and/or as starting point for development of anti-nociceptive therapeutic agents with novel mechanism of action.  This assay was used as an alternate secondary screen to uHTS Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay AID 2073. Terbium HTRF in dose response Assay materials: 1) Glutathione S-transferase (GST)-fusion protein (GST-M15) from assay provider. 2) Fluorescein labelled N-type Ca2+ channel carboxyl-terminal peptide (fluorescein-NC peptide) corresponding to the carboxyl-terminal tail of CaV2.2 protein (Bio Peptide lot# 0610096426) 3) Anti-GST monoclonal antibody labeled with terbium Tb-anti-GST antibody (Invitrogen cat# PV3551). 4) Tween-20 (Sigma cat#9416) 5) Bovine Serum Albumin (Sigma cat# A7888) Working solutions: 1. Assay buffer: 25 mM HEPES, pH 7.2, 100mM NaCl,0.1% BSA, 0.005% Tween-20 2. Mint1-PDZ working solution (2X final concentration) contains 10 nM GST-MINT-PDZ and 20 nM Tb-anti-GST 3. Fluorescein-NC peptide- (2X final concentration) contained 0.5 nM fluorescein-NC peptide. 4. Unlabelled  NC peptide-(2X final concentration) contained 0.5 nM unlabelled-NC peptide. Dose Response assay 1) Make Mint1 PDZ working solution.  Let sit 60 minutes at room temperature 2) Serial compound dilutions: dispense 70nL compounds in serial dilution using Labcyte Echo 550 to 1536 well white plates (Corning #3725) 3) Dispense 4 uL Mint1-PDZ working solution to each well 1536 well white plates (Corning #3725) 4) Incubate for 30 mins 5) Dispense 4 uL unlabelled NC peptide working solution to columns 1 & 2 6) ispense 4 uL of fluorescein-NC peptide working solution to columns 3-48 7) Seal plate. Spin down plate at 1000 rpm on 5810 centrifuge. 8) Incubate plate 20 hours at room temperature. 9) Spin down plate at 1000 rpm on 5810 centrifuge. 10) Read plate on a BMG Labtech PheraStar in a Homogeneous Time-Resolved Fluorescence mode (Ex: 337 nm; Em: 620/665 nm) within 10 min
bao:BAO_0001077 "2073_1" ; # "is alternate confirmatory assay of" -> "2073_1"
bao:BAO_0000812 "2093" ; # "has summary assay" -> "2093"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001078 bao:BAO_0001096 ; # "has orthogonal assay technology" -> "orthogonal assay technology"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000223 ; # "has assay format" -> "protein complex format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000280 ; # "has participant" -> "ion channel"
bao:BA0_0090012 bao:BAO_0000365 ; # "has participant" -> "cytosolic protein" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_00020101 ; # "is bioassay type of" -> "protein-protein interaction assay"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Fluorescein-NC peptide/GST-MINT-PDZ" ; # "protein-protein" -> "Fluorescein-NC peptide/GST-MINT-PDZ"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000207 bao:BAO_0000004 ; # "has detection method" -> "time resolved fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "To identify small molecule inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide" ; # "screening campaign name" -> "To identify small molecule inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide"
bao:BAO_0002853 "uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay" ; # "has assay title" -> "uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "20 hour" ; # "has incubation time value" -> "20 hour"
bao:BA0_0090012 "unlabeled NC peptide" ; # "has participant" -> "unlabeled NC peptide"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Ilya Bezprozvanny" ; # "material entity assay provider" -> "Ilya Bezprozvanny" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000693 ; # "has participant" -> "HEPES" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0001038 ; # "has participant" -> "Tween 20" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BA0_0090012 "Voltage-dependent N-type calcium channel subunit alpha-1B" ; # "has participant" -> "Voltage-dependent N-type calcium channel subunit alpha-1B"
bao:BA0_0090012 "Amyloid beta A4 precursor protein-binding family A member 1" ; # "has participant" -> "Amyloid beta A4 precursor protein-binding family A member 1"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_10116> ; # "has organism" -> "Rattus norvegicus"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Q00975" ; # "uniprot ID" -> "Q00975"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "O35430" ; # "uniprot ID" -> "O35430"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10116" ; # "NCBI taxonomy ID" -> "10116"
bao:BAO_0002662 bao:BAO_0000644 ; # "has quality" -> "truncated"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0002622 bao:BAO_00020127 ; # "has purity value" -> "purified"
bao:BAO_0000502 "\"Anti-GST monoclonal antibody labeled with europium cryptate, EuK-anti-GST-mAb, Cisbio cat 61GSTKLB\"" ; # "antibody" -> ""Anti-GST monoclonal antibody labeled with europium cryptate, EuK-anti-GST-mAb, Cisbio cat 61GSTKLB""
bao:BA0_0090012 "Fluorescein" ; # "has participant" -> "Fluorescein"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000705 ; # "uses detection instrument" -> "PHERAstar Plus"
bao:BAO_0000737 bao:BAO_0000863 ; # "has manufacturer" -> "BMG Labtech" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "337 nanometer" ; # "has excitation wavelength value" -> "337 nanometer"
bao:BAO_0002918 "620 nanometer" ; # "has emission wavelength value" -> "620 nanometer"
bao:BAO_0002918 "665 nanometer" ; # "has emission wavelength value" -> "665 nanometer"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie" ; # "Annotated by" -> "kunie"
